Now Approved: SYFOVRE (pegcetacoplan injection) – 3/2/23

Now Approved: SYFOVRE (pegcetacoplan injection) – 3/2/23

Now Approved: SYFOVRE™ (pegcetacoplan injection) Email content sponsored by Apellis Pharmaceuticals, Inc. Email content sponsored by Apellis Pharmaceuticals, Inc.  NOW APPROVED:The first and only treatment proven to slow lesion growth rate in GA secondary to...